Risk of heart failure with abiraterone versus enzalutamide amongst patients diagnosed with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
Authors: Mohit Mirchandani, Akhil Jain, Rupak Desai
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e24029
Source:
Full article
Abstract
e24029